Anatabine dicitrate Catalog No.:M14797-2 Bcr-Abl ubiquitination and Usp9x inhibition

Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis

but is involved in pathways of lipid metabolism and is incorporated into triglycerides along with endogenous fatty acids

MC1568 could be orally dosed to mice at 50 mg/kg once per day (formulation: 0

CAS Number: 1262036-49-6

1'-biphenyl]-4-yl]-2-oxo-1

Anatabine dicitrate Catalog No.:M14797-2 Bcr-Abl ubiquitination and Usp9x inhibitionAnatabine dicitrate is a tobacco alkaloid that can cross the blood brain barrier. Anatabine dicitrate is a potent 42 nAChR agonist. Anatabine dicitrate inhibits NF B activation lower amyloid (A) production by preventing the cleavage of amyloid precursor protein (APP). Anatabine dicitrate has anti inflammatory effects and has the potential for neurodegenerative disorders treatment. Product information Molecular Weight: 544. 46 Formula: C22H28N2O14